S H L Telemedicine Ltd (SHLTN.S)

SHLTN.S on Swiss Exchange

3:11am EST
Change (% chg)

CHF0.19 (+2.34%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for SHLTN.S


SHL Telemedicine Ltd (SHL) is an Israel-based company engaged in developing and marketing personal telemedicine solutions, with a focus on cardiovascular and related diseases. Personal telemedicine is the transmission of medical data by an individual, from a remote location, to a medical call center through telecommunication... (more)


Beta: 0.47
Market Cap(Mil.): CHF88.67
Shares Outstanding(Mil.): 10.88
Dividend: --
Yield (%): --


  SHLTN.S Industry Sector
P/E (TTM): 80.95 29.54 34.30
EPS (TTM): 0.10 -- --
ROI: 1.14 6.98 14.74
ROE: 1.43 19.34 15.95
Search Stocks

BRIEF-S H L Telemedicine: update regarding merger transaction

* Has given further consideration to Shanghai Jiuchuan Investment (Group) Co. Ltd.'s request for extension of period to fulfil certain closing conditions under agreement and plan of merger Source text for Eikon: Further company coverage: (Gdynia Newsroom)

12 Nov 2015

BRIEF-S H L Telemedicine informed of delay in obtaining government approval for transaction

* Was informed on Wednesday by Shanghai Jiuchuan Investment (Group) Co. Ltd. that the relevant authorities of the People's Republic of China have not yet approved the transactions contemplated under the Agreement and Plan of Merger dated as of July 24, 2015 by and among SHL, Shanghai Jiuchuan Investment (Group) and its Israeli subsidiary Jinoran Mergers (2015) Ltd.

15 Oct 2015

BRIEF-S H L Telemedicine H1 adjusted revenue up 25.4 pct at $22.3 mln

* H1 adjusted revenues of $22.3 million (up 25.4 percent in constant currency to $26.2 million)

31 Aug 2015

BRIEF-Winsan Shanghai Medical's controlling shareholder to acquire Israel's SHL Telemedicine

July 28 Winsan Shanghai Medical Science And Technology

28 Jul 2015

BRIEF-S H L Telemedicine says Shanghai Jiuchuan to acquire SHL Telemedicine

* Shareholders in SHL to receive 10.5 Swiss francs ($10.94) in cash per share (subject to applicable tax withholding)

27 Jul 2015

BRIEF-S H L Telemedicine Q1 net income up at $1.4 million

* Revenues of $9.5 million in Q1 2015, up 4.7 pct at constant exchange rates

28 May 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
Provider : GlobalData
Provider : Wright Reports
Provider : Sadif Analytics Prime
Provider : Sadif Analytics Prime

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks